Emotionally, many people describe a sense of unease, a fear that they will lose control or that their hard work will disappear
86,87 Differing from the effects observed in T2DM, the therapeutic efficacy of dulaglutide for MASLD is not particularly compelling based on current statistics
La Semaglutida,anlogos GLP1( Ozempic , Rybelsus y Wegovy) y Tirzepatida, dual GIP / GLP-1 ( Mounjaro) se utilizan actualmente en el tratamiento de la diabetes mellitus tipo 2 y, en el manejo de la obesidad.Aunque muchos pacientes los conocen por su nombre comercial, es fundamental saber que una misma molcula puede comercializarse con diferentes nombres, dosis e indicaciones
In March 2024, the FDA approved semaglutide (Wegovy) not just for weight loss but also to reduce cardiovascular risk in adults with known heart disease
The current approved dose of exenatide is 5 or 10 g given twice-daily